Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 30th June 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
Sparrow Wealth Management's Q2 2026 letter emphasizes the importance of focusing on corporate earnings fundamentals rather than geopolitical headlines. The quarter saw strong market performance with the S&P 500 returning 15.20%, international stocks gaining 11.99%, and bonds rising 1.55%. Emerging markets stocks, U.S. small value stocks, and the S&P 500 were the best performing asset classes. The letter highlights how markets recovered from the Iran conflict, with the S&P 500 falling 5% in March but finishing June more than 9% above pre-conflict levels. This recovery was driven by strong corporate earnings, with 85% of companies exceeding first-quarter estimates versus a 73% long-term average. Wall Street's consensus 2026 EPS growth estimate increased from 13% to 22% during the year. The manager reinforces the lesson from prior quarters that geopolitical market declines are typically temporary, and investors should avoid making decisions based on negative headlines. Strong earnings expectations continue to outweigh geopolitical uncertainty as the primary driver of market performance.
Long-term market performance is driven by corporate earnings expectations rather than geopolitical headlines, and investors should maintain discipline during periods of uncertainty as markets have historically demonstrated resilience and recovery.
The manager maintains a constructive outlook based on strong corporate earnings fundamentals. While acknowledging ongoing geopolitical uncertainty, the letter emphasizes that future earnings expectations are the primary driver of long-term market performance rather than headlines. The manager expects earnings growth to continue supporting markets despite unsettling news cycles.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jul 8 2026 | 2026 Q2 | - | Asset Class Performance, earnings, emerging markets, Geopolitical Risk, Market Recovery, small caps | - | Markets delivered strong Q2 2026 returns led by emerging markets and small caps, with the S&P 500 gaining 15.20%. Despite Iran conflict volatility in March, markets recovered fully by June, driven by exceptional corporate earnings with 85% of companies beating estimates. Wall Street raised 2026 EPS growth forecasts from 13% to 22%. Earnings fundamentals continue to trump geopolitical headlines as the key market driver. |
| Apr 7 2026 | 2026 Q1 | - | diversification, Geopolitical, international, Iran, oil, small cap, value | - | Q1 2026 demonstrated diversification's value as geopolitical tensions with Iran caused S&P 500 to decline 4.34% while international and value stocks posted gains. The manager emphasizes that reacting to headlines is poor investment strategy, citing historical data showing geopolitical sell-offs are typically short-lived with markets recovering within 6-12 months. |
| Jan 8 2026 | 2025 Q4 | - | diversification, global, international, Patient Capital, value | - | Strong 2025 performance vindicated international diversification strategy with international value stocks delivering exceptional returns of 45-52%. Declining dollar, attractive valuations, and foreign government spending drove outperformance. Manager emphasizes patient value investing approach similar to Warren Buffett, reinforcing long-term diversification benefits after years of international underperformance. |
| Jul 4 2025 | 2025 Q2 | VBTLX, VOO, VTIAX | diversification, Dollar, international, small caps, Trade Policy, value | - | International small and value stocks led performance in Q2 2025 despite trade policy volatility that caused a 10% market drop and recovery. Dollar weakness boosted international returns. The manager reinforces diversification as the best defense against ongoing uncertainty from trade negotiations, tax legislation, rate cuts, and AI developments. |
| Apr 5 2025 | 2025 Q1 | DFALX, DFGBX, DFISX, DFREX, DIPSX, VFIAX, VTWIX | diversification, international, REITs, tariffs, value | - | Q1 2025 demonstrated diversification's power as international value stocks surged over 10% while US markets declined on tariff fears. Sparrow Wealth emphasizes maintaining global positioning despite policy uncertainty, noting that diversification has worked magnificently. Key risks include tariff-driven economic slowdown and inflation resurgence, but the firm advises against reactive portfolio changes. |
| Oct 6 2024 | 2024 Q3 | CCL-B.TO, ENGH.TO, IFC.TO, L.TO, OTEX.TO, PBH.TO, SJ.TO, TIH.TO, TRI.TO, TVK.TO | AI, Canada, dividends, energy, gold, materials, technology |
OTEX.TO TIH.TO PBH.TO L.TO |
Bristol Gate's Canadian dividend growth strategy lagged in Q3 as gold miners drove TSX gains. Strong AI-related performance from Open Text and Toromont offset weakness in Thomson Reuters and TerraVest. Added Loblaw, sold Enghouse. Despite underperformance from lacking gold exposure, management maintains conviction in high-quality dividend growers through market cycles. |
| Jul 4 2024 | 2024 Q2 | 000333.SZ, 0005.HK, 002714.SZ, 0700.HK, 0981.HK, 1024.HK, 2899.HK, 300274.SZ, 300750.SZ, 600519.SS, BABA, BIDU | AI, China, consumer, industrials, semiconductors, technology, valuation | - | Guinness China A Share Fund returned 23.6% in Q3 but underperformed by avoiding overvalued AI names that drove market gains. The manager views these stocks as trading on uncertain future cash flows similar to China's 2021 COVID rally peak. Despite weak macro data, the fund maintains exposure to structural growth themes while staying disciplined on valuations. |
| Apr 5 2024 | 2024 Q1 | BRK-B, JPM, MSFT, NVDA, PLTR | AI, Fed policy, growth, healthcare, inflation, tariffs, technology | - | Oak Ridge's growth strategy capitalizes on AI transformation while managing concentration risk across market caps. Strong technology performance offset healthcare headwinds in Q2. The firm actively trims winners and cuts losers, positioning for Fed rate cuts and 2026 growth. Key risks include elevated valuations and geopolitical uncertainty, but AI innovation momentum supports the long-term thesis. |
| Jan 5 2024 | 2023 Q4 | BABA, BTI, CHTR, CRDA.L, DGE.L, FAST, HILS.L, MCO, MSFT, ORCL, PM, POOL, REL.L, SCHW, SGE.L, SPX.L, TMO, TXN, WSO | Diversified, Funds, Investment Trust, Long Term, Private Capital, Public Companies | - | Caledonia delivered 4.4% NAV total return with strong Public Companies and Private Capital performance. Permanent capital structure enabled opportunistic deployment during market volatility, adding Charles Schwab. Oracle's AI-driven gains allowed profitable realization. Stonehage Fleming sale at 3.2x cost demonstrates patient value creation. Strong balance sheet with £430m liquidity positions for continued opportunity capture despite near-term market uncertainty. |
| Oct 5 2023 | 2023 Q3 | NVDA, TSLA | AI, growth, healthcare, large cap, technology, Valuations | - | Oak Ridge's Large-Cap strategy underperformed in Q4 due to GLP-1 trimming and Tesla avoidance, but delivered strong two-year returns. The manager maintains conviction in mega-cap technology leaders and healthcare overweights, viewing current 23.5X valuations as justified by AI's transformative potential despite political uncertainties around Trump's policies. |
| Jul 5 2023 | 2023 Q2 | - | AI, growth, healthcare, large cap, Quality, rates, semiconductors, technology | - | Oak Ridge's growth strategies navigated Q3's rotation from mega-cap to small-cap leadership, maintaining benchmark-weight tech exposure while adding value through superior stock selection. Despite healthcare headwinds from cooling GLP-1 momentum, strong semiconductor and cybersecurity picks drove performance. The firm increased turnover to capitalize on shifting opportunities, maintaining high conviction in quality growth positioning for expected volatility ahead. |
| Apr 6 2023 | 2023 Q1 | CSCO, MSFT | AI, growth, healthcare, Market Concentration, Mega Cap, technology, Valuations | - | Oak Ridge outperformed across strategies in Q2 2024, led by their largest position in GLP-1 pharmaceuticals and strong technology stock selection. While acknowledging current mega-cap concentration and elevated valuations, they position for expected rotation into underrepresented sectors like Healthcare. The firm maintains their 34-year discipline of focusing on sustainable business models and reasonable valuations. |
| Jan 9 2023 | 2022 Q4 | - | - | - | |
| Oct 6 2022 | 2022 Q3 | - | - | - | |
| Jul 7 2022 | 2022 Q2 | - | - | - | |
| Apr 6 2022 | 2022 Q1 | - | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q2 |
EarningsCorporate earnings exceeded expectations significantly in Q2 2026, with approximately 85% of companies beating first-quarter estimates versus a long-term average of 73%. Wall Street consensus for 2026 EPS growth increased from 13% at year start to 22%, demonstrating strong fundamental performance that outweighed geopolitical uncertainty. |
EPS Growth Earnings Beats Corporate Performance |
Risk AppetiteMarkets demonstrated resilience following the Iran conflict, with the S&P 500 recovering from a 5% decline in March to finish 9% above pre-conflict levels by June. The letter emphasizes that geopolitical tensions eased during the quarter and investors should avoid making decisions based on negative headlines, as history shows markets consistently recover over time. |
Market Recovery Geopolitical Risk Investor Behavior | |
Emerging MarketsEmerging markets stocks were the best performing asset class in Q2 2026, with DFA Emerging Markets Core returning 22.93% for the quarter and 47.59% over one year. This represented the strongest performance across all asset classes tracked in the letter. |
EM Equities Asset Class Performance | |
Small CapsU.S. small cap stocks delivered strong performance in Q2 2026, with DFA U.S. Small returning 16.70% for the quarter and 31.10% over one year. Small value stocks also performed well with 33.18% one-year returns, ranking among the top performing asset classes. |
Small Cap Equities Value Factor | |
| 2026 Q1 |
DiversificationThe letter emphasizes how diversification helped offset S&P 500 declines during Q1 2026. While large U.S. tech companies dragged the S&P 500 down 4.34%, international large, emerging markets, U.S. small cap value, and U.S. large value stocks all posted gains. The manager uses this as a reminder of why diversification still matters in uncertain times. |
Asset Allocation Risk Management International Value Small Cap |
| 2025 Q4 |
InternationalInternational stocks were the standout performer in 2025, surging 32.18% for the year, supported by a declining U.S. dollar, attractive valuations, and increased spending by foreign governments. The firm has long advocated for international investing as part of a diversified portfolio, and while these markets have underperformed in past years, their patience was richly rewarded in 2025. |
International Diversification Valuations Currency |
ValueThe letter emphasizes value investing principles shared with Warren Buffett, including patient capital allocation and staying the course through market turbulence. International large value and small value stocks were among the best performing asset classes during the quarter, validating the value approach. |
Value Patience Buffett Temperament | |
| 2025 Q2 |
DiversificationThe manager emphasizes diversification as the best defense against market uncertainty, particularly highlighting how international small and value stocks outperformed during the quarter. The letter reinforces that this year has provided ample proof of diversification's value. |
International Value Small Caps Risk Management Asset Allocation |
Trade PolicyPresident Trump's announcement of broader and steeper tariffs targeting major U.S. trading partners caused a 10% market drop in one week during April. A subsequent 90-day pause on tariffs prompted a swift market recovery by early May. |
Tariffs Trade Negotiations Policy Risk Market Volatility | |
DollarThe U.S. dollar's roughly 11% decline relative to other major currencies has been a key driver behind international stocks' outperformance, acting as a tailwind for companies generating earnings in euros, yen, and other non-dollar denominations. |
Currency International Earnings Translation FX Impact | |
| 2025 Q1 |
Trade PolicyThe potential for widespread tariffs represents real risk to slowing down the US economy and increased risk for inflation to reignite as importers pass along increased costs to consumers. |
Tariffs Inflation Trade |
| 2024 Q3 |
DividendsThe strategy focuses on high dividend growth companies and continues to outpace the index in dividend growth metrics. The manager emphasizes owning attractively priced, high quality, high dividend growers as their core investment philosophy. |
Dividend Growth Income Quality Yield |
AIAI continues to permeate businesses with uranium and natural gas stocks benefiting from data center adoption. Open Text reported strong cloud bookings driven by their new AI-driven Titanium X platform. Toromont is positioned to capitalize on AI-fueled data center construction. |
Data Centers Cloud Technology Infrastructure | |
GoldGold has doubled in value over the last two years, moving parabolically higher similar to the late 1970s. The Materials sector delivered a 37.8% return driven by gold's continued ascent on inflation concerns and central bank demand. |
Precious Metals Inflation Central Banks Materials | |
| 2024 Q2 |
AIChina's onshore AI stocks have driven significant market gains but are viewed as significantly overvalued with 70-90% of valuations based on uncertain future cash flows. The manager avoids these names, comparing current valuations to the peak of China's COVID rally in early 2021. |
Artificial Intelligence Semiconductors Technology Valuation Growth |
ChinaThe fund focuses exclusively on China A shares with structural growth themes built on demographic changes, production advances, and technology applications. Economic data remains weak despite equity market strength, with continued real estate weakness and policy stimulus measures. |
A Shares Onshore Structural Growth Demographics Policy | |
SemiconductorsThe semiconductor sector has been a major driver of market performance, particularly AI-related names like Foxconn Industrial Internet and Cambricon Technologies. The fund maintains selective exposure through companies like Shengyi Technology while avoiding the most speculative AI names. |
Chips Technology Hardware AI Infrastructure Manufacturing Electronics | |
| 2024 Q1 |
AITechnology has been at the forefront with great excitement over the transformative effects of AI, evidenced by sold-out Nvidia Blackwell chips and strong Microsoft Azure results. AI will likely continue to create transformative new opportunities at an unprecedented pace. The market concentration in AI-dominant fields is notable with all but Berkshire and J.P. Morgan among the top 10 S&P 500 constituents being in AI-dominant fields. |
Artificial Intelligence Technology Innovation Nvidia Microsoft |
GLP1Healthcare holdings included long-term positions in a leading pharmaceutical company that had soared due to their leading GLP-1 drug and robust pipeline. The drug company is believed to be poised for future upside revisions due to further advances in weight loss and new drugs for Alzheimer's and cancer. A health and wellness company spiked 67% on their involvement in adding GLP-1 drugs to their lineup. |
Weight Loss Pharmaceuticals Healthcare Drug Development | |
Trade PolicyThe quarter began with a panic selloff in reaction to triple-digit tariffs threatened on President Trump's Liberation Day. Fed concerns over the effects of tariffs on inflation and interest rates seemed to ease the Draconian rhetoric. Companies have reduced capital investment and labor hiring while trimming estimates for 2025, with surveys suggesting most companies plan to pass increased costs on to their customers. |
Tariffs Protectionism Inflation Policy | |
| 2023 Q4 |
AIOracle, Microsoft, and Alibaba Group were strong performers driven by their cloud businesses and AI-related services. Oracle's share price rose sharply following AI-related announcements which led to significant re-rating of the shares. The company's AI focus contributed to strong returns across the Capital portfolio. |
Cloud Software Technology Growth |
Private CapitalThe Private Capital pool delivered 7.7% returns over six months, driven primarily by the agreed sale of Stonehage Fleming and good operational performance from AIR-serv. The strategy focuses on cash generative businesses with strong growth potential, typically investing £50m to £150m using low levels of leverage. |
Buyouts Direct Investment Value Creation Long Term | |
DividendsThe Income portfolio aims to deliver an initial yield on invested cost of 3.5% with overall dividend from holdings growing ahead of inflation over the longer term. Caledonia received a dividend of £24.5m from AIR-serv during the six-month period, bringing total dividends received since acquisition to £30.7m. |
Income Yield Distribution Growth | |
| 2023 Q3 |
AIAI represents considerably greater transformative innovation than previous technologies. The U.S. economy is expected to grow between 2% and 2.5% in 2025, fueled heavily by investments in AI and security. Jobs data will be pressured by AI over time. |
Artificial Intelligence Innovation Economic Growth Technology Investment |
TariffsTrump's proposed tariffs are at the forefront of policy discussions. There is little discussion about retaliatory reactions from China and other targeted countries. The ultimate resolutions will likely add inflationary pressure and continue to strengthen the U.S. dollar. |
Trade Policy China Inflation Dollar Strength | |
GLP1A correction in the leading GLP-1 manufacturer following a multi-year run during which the position was trimmed on valuation. The fourth quarter correction was due to a cooling on the GLP-1 front, affecting the largest holding. |
Pharmaceuticals Weight Loss Valuation | |
| 2023 Q2 |
RatesFed cut rates 50 basis points with further cuts expected to be data dependent. Lower rates improve affordability of homes and big ticket items while supporting consumer spending. Rate-sensitive sectors like Real Estate and Utilities performed best during the quarter. |
Fed Interest Rates Monetary Policy Real Estate Utilities |
GLP1Healthcare sector took a break during the quarter, particularly the red hot GLP-1 weight loss area. Oak Ridge remains heavily overweight in the leader of the transformative weight loss field despite trimming their largest active bet in late June. |
Weight Loss Healthcare Pharmaceuticals Obesity Medical Devices | |
AITechnology changes were made late in the quarter to be better positioned not only for direct AI plays, but other beneficiaries of a changing landscape. Strong stock selection in semiconductors and cloud networking positions boosted returns. |
Artificial Intelligence Semiconductors Cloud Technology Innovation | |
CybersecurityStrong stock selection in cyber security positions contributed to performance. However, the portfolio suffered a severe loss from selling a leading cyber security provider that caused a major software shutdown throughout the U.S. |
Cyber Security Software Technology Risk Management Infrastructure | |
| 2023 Q1 |
AIAI spending has driven significant market concentration in mega-cap technology companies. IT budgets have shifted away from cloud, security and other initiatives to fund AI programs, but the disproportionate spend should begin to ease over the coming quarters. While there may have been excess spend among the largest AI chip customers over the past couple of years, it does not compare to the Telecom outlay on fiber optics during the dot-com era. |
Artificial Intelligence Technology Semiconductors Cloud IT Spending |
GLP1The leading GLP-1 pharmaceutical maker is the portfolio's largest active bet and has delivered over 50% returns for two consecutive years. The manager remains highly optimistic about the company's potential to maintain their market leading position in the weight loss category and benefit from several other large areas of opportunity, though they have trimmed exposure to be prudent. |
Weight Loss Pharmaceuticals Diabetes Healthcare Biotechnology | |
SemiconductorsSemiconductor companies have been key contributors to portfolio performance, particularly those manufacturing products to make their customers' systems run more efficiently. The sector has benefited from AI-related demand, though the manager expects demand should slow and multiples contract over time. |
Chips Technology AI Hardware Manufacturing |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| - | Fund Letters | Sparrow Wealth Management | OTEX.TO | Open Text Corporation | Information Technology | Systems Software | Bull | Toronto Stock Exchange | AI platform, Cloud computing, Content Management, Digital transformation, Dividend Growth, Enterprise software, SaaS, share repurchase | Login |
| - | Fund Letters | Sparrow Wealth Management | TIH.TO | Toromont Industries Ltd. | Industrials | Trading Companies & Distributors | Bull | Toronto Stock Exchange | AI infrastructure, Caterpillar Dealer, Cooling Solutions, data centers, Equipment Rental, Industrial Equipment, Power generation, US Expansion | Login |
| - | Fund Letters | Sparrow Wealth Management | PBH.TO | Premium Brands Holdings Corporation | Consumer Staples | Packaged Foods & Meats | Bull | Toronto Stock Exchange | consumer staples, Debt Deleveraging, Food Manufacturing, New Product Launches, production capacity, Sale Leaseback, Specialty-Foods, US Expansion | Login |
| - | Fund Letters | Sparrow Wealth Management | L.TO | Loblaw Companies Limited | Consumer Staples | Food & Staples Retailing | Bull | Toronto Stock Exchange | Defensive Consumer Staples, digital commerce, Dividend Growth, grocery retail, loyalty program, market leadership, Multi-Format Strategy, Pharmacy Services | Login |
| TICKER | COMMENTARY |
|---|---|
| No ticker commentary found. | |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||